FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:2288-2290 December 11, 2003 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Nankivell, B. J. PubMed Citation

Long-term survival of kidney transplants (renal allografts) has changed little during the past decade, despite dramatic improvements in short-term survival. Most late renal allograft loss, other than that associated with the death of the patient, has been attributed to progressive renal dysfunction, termed "chronic allograft nephropathy" (or CAN), a confusing term that lacks a rigorous consensus definition.

Chronic allograft nephropathy entered prime time in 1993 as a category in the Banff diseases of kidney-transplant diseases that included at least four entities that could not always be differentiated on biopsy (chronic rejection, chronic toxic effects of cyclosporine; hypertensive vascular disease; and . . . [Full Text of this Article]

Source Information

From the Department of Pathology, Massachusetts General Hospital, Boston.

This article has been cited by other articles:

• Vidyasagar, A., Reese, S., Acun, Z., Hullett, D., Djamali, A. (2008). HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosis. Am. J. Physiol. Renal Physiol. 295: F707-F716 [Abstract] [Full Text]  
• Djamali, A. (2007). Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts. Am. J. Physiol. Renal Physiol. 293: F445-F455 [Abstract] [Full Text]  
• Fiorina, P., Perseghin, G., De Cobelli, F., Gremizzi, C., Petrelli, A., Monti, L., Maffi, P., Luzi, L., Secchi, A., Del Maschio, A. (2007). Altered Kidney Graft High-Energy Phosphate Metabolism in Kidney-Transplanted End-Stage Renal Disease Type 1 Diabetic Patients: A cross-sectional analysis of the effect of kidney alone and kidney-pancreas transplantation. Diabetes Care 30: 597-603 [Abstract] [Full Text]  
• Djamali, A., Sadowski, E. A., Muehrer, R. J., Reese, S., Smavatkul, C., Vidyasagar, A., Fain, S. B., Lipscomb, R. C., Hullett, D. H., Samaniego-Picota, M., Grist, T. M., Becker, B. N. (2007). BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction. Am. J. Physiol. Renal Physiol. 292: F513-F522 [Abstract] [Full Text]  
• Kambham, N., Nagarajan, S., Shah, S., Li, L., Salvatierra, O., Sarwal, M. M. (2007). A Novel, Semiquantitative, Clinically Correlated Calcineurin Inhibitor Toxicity Score for Renal Allograft Biopsies. CJASN 2: 135-142 [Abstract] [Full Text]  
• Djamali, A., Samaniego, M., Muth, B., Muehrer, R., Hofmann, R. M., Pirsch, J., Howard, A., Mourad, G., Becker, B. N. (2006). Medical Care of Kidney Transplant Recipients after the First Posttransplant Year. CJASN 1: 623-640 [Abstract] [Full Text]  
• Rowshani, A. T., Scholten, E. M., Bemelman, F., Eikmans, M., Idu, M., van Groningen, M. C.R., Surachno, J. S., Mallat, M. J.K., Paul, L. C., de Fijter, J. W., Bajema, I. M., ten Berge, I., Florquin, S. (2006). No Difference in Degree of Interstitial Sirius Red-Stained Area in Serial Biopsies from Area under Concentration-over-Time Curves-Guided Cyclosporine versus Tacrolimus-Treated Renal Transplant Recipients at One Year. J. Am. Soc. Nephrol. 17: 305-312 [Abstract] [Full Text]  
• Revelo, M. P., Federspiel, C., Helderman, H., Fogo, A. B. (2005). Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-{gamma}. Nephrol Dial Transplant 20: 2812-2819 [Abstract] [Full Text]  
• Chapman, J. R., O'Connell, P. J., Nankivell, B. J. (2005). Chronic Renal Allograft Dysfunction. J. Am. Soc. Nephrol. 16: 3015-3026 [Abstract] [Full Text]